2024 Financial Report | Insulin Low Price Competition, Gan Li Pharmaceutical's Gains and Losses

Go out to sea

wallstreetcnApr 25 23:02 ET

2024 Financial Report | After the dividend ratio is close to 100%, Donga Ejiao still has 8 billion

Extravagant dividends

wallstreetcnMar 22 04:25 ET

2024 Financial Report | BGI's profit fell by more than 80%, making it difficult to find the next outlet

The era of gold everywhere is over

wallstreetcnFeb 29 23:48 ET

Teva Pharmaceutical Investments Singapore, A Subsidiary Of Teva Pharmaceutical Industries And Jiangsu Nhwa Pharmaceutical Formed A Partnership To Market And Distribute Teva's Austedo (Deutetrabenazine) For Neurodegenerative And Movement Disorders

Teva Pharmaceutical Investments Singapore, A Subsidiary Of Teva Pharmaceutical Industries And Jiangsu Nhwa Pharmaceutical Formed A Partnership To Market And Distribute Teva's Austedo (Deutetrabenazine

BenzingaFeb 26 07:08 ET

Is the healthcare market recovering? Mindray Healthcare acquires control of Whitney Healthcare at 25% premium | Insight Research

In the new year, A was born, and the leading device company Mindray entered the cardiovascular field at a premium.

wallstreetcnJan 28 18:56 ET

“Yemao” Tongze Healthcare's revenue growth in the third quarter was close to stagnation, and net profit fell 5.58% year on year | Financial News

Tongce Medical's revenue for the first three quarters was 2.85 billion yuan, up 2.12% year on year; net profit to mother was 512 million yuan, a decrease of 0.67% year on year.

wallstreetcnOct 24, 2023 09:16 ET